enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Trastuzumab - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab

   Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. [ 31 ] [ 28 ] [ 32 ] [ 33 ] It is specifically used for cancer that is HER2 receptor positive . [ 31 ]

3. Trastuzumab/hyaluronidase - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab/hyaluronidase

   Clinical trial number NCT01566721 for "A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (SafeHER)" at ClinicalTrials.gov

4. Trastuzumab deruxtecan - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab_deruxtecan

   Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). [11] [12] It is licensed for the treatment of breast cancer or gastric or gastroesophageal ...

5. Trastuzumab emtansine - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab_emtansine

   Each molecule of trastuzumab emtansine consists of a single trastuzumab molecule with several molecules of DM1, a cytotoxic maytansinoid, attached. [21] SMCC, or succinimidyl trans -4-(maleimidylmethyl)cyclohexane-1-carboxylate, is a heterobifunctional crosslinker , a type of chemical reagent that contains two reactive functional groups , a ...

6. TCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/TCH_(chemotherapy)

   TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. References

7. FDA Approves Genentech's Kadcyla (Ado-Trastuzumab ... - AOL

   www.aol.com/news/2013-02-22-fda-approves-genen...

   FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating HER2-Positive Metastatic Breast Cancer -- New Personalized Medicine Helped People in ...

8. Ford recalls 2024: Check the list of models recalled this year

   www.aol.com/ford-recalls-2024-check-list...

   Several recalls were issued in 2024 for Ford Motor Company vehicles. The recall report data is from Jan. 1, 2024, to Dec. 27, 2024. The U.S. Department of Transportation (DOT) compiles data from ...

9. Pertuzumab/trastuzumab/hyaluronidase - Wikipedia

   en.wikipedia.org/wiki/Pertuzumab/trastuzumab/...

   The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...